0001104659-17-049236.txt : 20170803 0001104659-17-049236.hdr.sgml : 20170803 20170803124333 ACCESSION NUMBER: 0001104659-17-049236 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170803 DATE AS OF CHANGE: 20170803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zealand Pharma A/S CENTRAL INDEX KEY: 0001674988 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-38178 FILM NUMBER: 171004035 BUSINESS ADDRESS: STREET 1: SMEDELAND 36 STREET 2: 2600 GLOSTRUP CITY: COPENHAGEN STATE: G7 ZIP: 00000 BUSINESS PHONE: 4588773600 MAIL ADDRESS: STREET 1: SMEDELAND 36 STREET 2: 2600 GLOSTRUP CITY: COPENHAGEN STATE: G7 ZIP: 00000 8-A12B 1 a16-11671_108a12b.htm 8-A12B

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

ZEALAND PHARMA A/S

(Exact name of registrant as specified in its charter)

 

 

Denmark

 

Not Applicable

(State of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

Smedeland 36

2600 Glostrup (Copenhagen)

Denmark

+45 88 77 36 00

(Address of principal executive offices and zip code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class
to be so registered

 

Name of each exchange on which
each class is to be registered

American Depositary Shares, each representing
one ordinary share

 

The NASDAQ Stock Market LLC

 

 

 

Ordinary shares, nominal value DKK 1 per share

 

The NASDAQ Stock Market LLC*

 

* Not for trading, but only in connection with the registration of the American Depositary Shares on The NASDAQ Stock Market LLC. The American Depositary Shares represent the right to receive the ordinary shares and are being registered under the Securities Act of 1933, as amended, pursuant to a separate Registration Statement on Form F-6. Accordingly, the American Depositary Shares are exempt from the operation of Section 12(a) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 12a-8 thereunder.

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.  x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.  o

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box.  o

 

Securities Act registration statement or Regulation A offering statement file number to which this form relates (if applicable): File No. 333-219184

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 


 

INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 1. Description of Registrant’s Securities to be Registered.

 

Zealand Pharma A/S (the “Registrant”) hereby incorporates by reference (a) the description of its ordinary shares, nominal value DKK 1 per share, to be registered hereunder under the heading “Description of Share Capital” (b) the description of its American Depositary Shares, each representing one ordinary share, to be registered hereunder contained under the heading “Description of American Depositary Shares,” (c) the information set forth under the heading “Material U.S. Federal Income Tax Considerations” and (d) the information set forth under the heading “Material Danish Federal Income Tax Considerations,”  in each case, in the Registrant’s Registration Statement on Form F-1 (File No. 333-219184), as originally filed with the Securities and Exchange Commission (the “Commission”) on July 6, 2017, as subsequently amended (the “Registration Statement”), and any prospectus that constitutes part of the Registration Statement and that is subsequently filed by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which information shall be deemed to be incorporated herein by reference.

 

Item 2. Exhibits.

 

Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

2


 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

ZEALAND PHARMA A/S

 

 

 

Date: August 3, 2017

By:

/s/ BRITT MEELBY JENSEN

 

Name:

Britt Meelby Jensen

 

Title:

Chief Executive Officer

 

3